alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Federal Register: February 24, 1999 (Volume 64, Number 36)]
[Notices]
[Page 9130]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24fe99-35]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Commodity Futures Trading Commission.

TIME AND DATE: 11:00 a.m., Friday, March 5, 1999.

PLACE: 1155 21st St., N.W., Washington, D.C., 9th Floor Conference
Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Surveillance Matters.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.
Jean A. Webb,
Secretary of the Commission.
[FR Doc. 99-4739 Filed 2-22-99; 3:25 pm]
BILLING CODE 6351-01-M
```

----

**======== RETURN    TO INDEX ========**

----
[Federal Register Volume 66, Number 124 (Wednesday, June 27, 2001)]
[Proposed Rules]
[Pages 34139-34140]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-15876]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[NC95-200034b; FRL-6994-1]


Approval and Promulgation of Implementation Plans; North 
Carolina: Approval of Revisions to Miscellaneous Volatile Organic 
Compounds Regulations Within the North Carolina State Implementation 
Plan

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: The EPA is proposing to approve the State Implementation Plan 
(SIP) revision submitted by the State of North Carolina for the purpose 
of adopting, amending and repealing regulations relating to volatile 
organic compounds (VOCs). In the Final Rules Section of this Federal 
Register, the EPA is approving the State's SIP revision as a direct 
final rule without prior proposal because the Agency views this as a 
noncontroversial submittal and anticipates no adverse comments. A 
detailed rationale for the approval is set forth in the direct final 
rule. If no significant, material, and adverse comments are received in 
response to this rule, no further activity is contemplated. If EPA 
receives adverse comments, the direct final rule will be withdrawn and 
all public comments received will be addressed in a subsequent final 
rule based on this rule. The EPA will not institute a second comment 
period on this document. Any parties interested in commenting on this 
document should do so at this time.

DATES: Written comments must be received on or before July 27, 2001.

[[Page 34140]]


ADDRESSES: All comments should be addressed to: Randy Terry at the EPA, 
Region 4 Air Planning Branch, 61 Forsyth Street, SW., Atlanta, Georgia 
30303.
    Copies of the State submittal(s) are available at the following 
addresses for inspection during normal business hours:
    Environmental Protection Agency, Region 4, Air Planning Branch, 61 
Forsyth Street, SW., Atlanta, Georgia 30303-8960. Randy Terry, 404/562-
9032.
    North Carolina Department of Environment, Health, and Natural 
Resources, 512 North Salisbury Street, Raleigh, North Carolina 27604.

FOR FURTHER INFORMATION CONTACT: Randy B. Terry at 404/562-9032.

SUPPLEMENTARY INFORMATION: For additional information see the direct 
final rule which is published in the Rules section of this Federal 
Register.

    Dated: January 5, 2001.
A. Stanley Meiburg,
Acting Regional Administrator, Region 4.
[FR Doc. 01-15876 Filed 6-26-01; 8:45 am]
BILLING CODE 6560-50-P
James McGOWAN, petitioner, v. UNITED STATES.

No. 16-6500.

Supreme Court of the United States

Nov. 28, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
* This order and judgment is not binding precedent, except under the

doctrines of law of the case, res judicata, and collateral estoppel. The court

generally disfavors the citation of orders and judgments; nevertheless, an order

and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3.

F I L E D

United States Court of Appeals

Tenth Circuit

JAN 6 1998

PATRICK FISHER

Clerk

UNITED STATES COURT OF APPEALS

FOR THE TENTH CIRCUIT

LUIS SANCHEZ,

Petitioner-Appellant,

v.

JOE SPRUNK, Warden; ATTORNEY

GENERAL OF THE STATE OF NEW

MEXICO,

Respondents-Appellees.

No. 97-2116

(D.C. No. CIV-96-37-MV)

(D. N.M.)

ORDER AND JUDGMENT*

Before BRORBY, BARRETT, and BRISCOE, Circuit Judges.

After examining the briefs and appellate record, this panel has determined

unanimously that oral argument would not materially assist the determination of

this appeal. See Fed. R. App. P. 34(a); 10th Cir. R. 34.1.9. The case is therefore

ordered submitted without oral argument.
-2-

Petitioner Luis Sanchez petitioned the district court for a writ of habeas

corpus pursuant to 28 U.S.C. § 2254. The district court dismissed the petition

and denied Mr. Sanchez a certificate of appealability. See id. § 2253(c). Since

Mr. Sanchez filed his petition in the district court prior to April 24, 1996, we

construe his application for a certificate of appealability in this court as an

application for a certificate of probable cause. See United States v. Kunzman,

125 F.3d 1363, 1364 n.2 (10th Cir. 1997).

Mr. Sanchez makes the following arguments: (1) his counsel rendered

ineffective assistance by failing to secure the services of an interpreter until the

state’s only witness finished testifying on direct examination; (2) his counsel was

ineffective by failing to present a defense, by failing to call witnesses and to

present evidence; (3) he was entitled to an evidentiary hearing on his ineffective

assistance of counsel claims; (4) the cumulative effect of counsel’s errors denied

him a fair trial; (5) the state trial court denied him his due process rights and right

to confront witnesses by admitting the officer’s hearsay statement concerning an

alleged arrangement for Mr. Sanchez to make a second cocaine sale; and (6) the

state trial court denied him his due process and confrontation rights by admitting

the officer’s hearsay testimony concerning the chain of custody of the cocaine

allegedly purchased from Mr. Sanchez on two different occasions.
-3-

For substantially the reasons stated in the well-reasoned order by the

magistrate judge dated February 11, 1997, adopted by the district court in its

order of March 11, 1997, we deny a certificate of probable cause. Accordingly,

this appeal is DISMISSED.

Entered for the Court

Wade Brorby

Circuit Judge
EXHIBIT 32.2








SECTION 1350 CERTIFICATION








In connection with the Quarterly Report of Teen Education Group,  Inc. (the "Company") on Form 10-Q for the quarter  ending September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"),  I, Robert L.  Wilson, President of the Company,  certify,  pursuant to 18 U.S.C.  Section 1350, as adopted pursuant  to Section 906 of the  Sarbanes-Oxley  Act of 2002,  that, to my knowledge:





(1)    The Report fully  complies with the  requirements  of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)    The information contained  in the  Report  fairly  presents,  in all material respects,  the financial  condition and results of operations of the Company.








Date: November 9, 2010
By:
/s/ ROBERT L. WILSONRobert L. WilsonPrincipal Financial Officer
Exhibit 24.1



POWER OF ATTORNEY



WHEREAS, BURLINGTON NORTHERN SANTA FE CORPORATION, a Delaware
corporation (the Company), will file with the Securities and Exchange Commission, under the provisions of the Securities Exchange Act of 1934, as amended, its Annual Report on Form 10-K for the fiscal year ended December 31, 2002; and



WHEREAS, the undersigned serve the Company in
the capacity indicated;



NOW, THEREFORE, the
undersigned hereby constitutes and appoints THOMAS N. HUND or JEFFREY R. MORELAND, his or her attorney with full power to act for him or her in his or her name, place and stead, to sign his or her name in the capacity set forth below, to the Annual
Report on Form 10-K of the Company for the fiscal year ended December 31, 2002, and to any and all amendments to such Annual Report on Form 10-K, and hereby ratifies and confirms all that said attorney may or shall lawfully do or cause to be done by
virtue hereof.



IN WITNESS WHEREOF, this Power of
Attorney has been executed by the undersigned this 14th day of February, 2003.



|/s/  Alan L. BoeckmannAlan L. Boeckmann, Director                                                 |  | /s/  John J. Burns, Jr.John J. Burns, Jr., Director
|------------------------------------------------------------------------------------------------- |  | ---------------------------------------------------
|                                                                                                 
|/s/  Bill M. LindigBill M. Lindig, Director                                                       |  | /s/  Vilma S. MartinezVilma S. Martinez, Director  
|                                                                                                 
|/s/  Marc F. RacicotMarc F. Racicot, Director                                                     |  | /s/  Roy S. RobertsRoy S. Roberts, Director        
|                                                                                                 
|/s/  Matthew K. RoseMatthew K. Rose, Director and Chairman, President and Chief Executive Officer |  | /s/  Marc J. ShapiroMarc J. Shapiro, Director      
|                                                                                                 
|/s/  J.C. Watts, Jr.J.C. Watts, Jr., Director                                                     |  | /s/  Robert H. WestRobert H. West, Director        
|                                                                                                 
|/s/  Edward E. Whitacre, Jr.Edward E. Whitacre, Jr., Director                                     |  | /s/  J. Steven WhislerJ. Steven Whisler, Director  
|                                                                                                 
|                                                                                                  |  | /s/  Michael B. YanneyMichael B. Yanney, Director
<PAGE>

										EXHIBIT 11

KENAN TRANSPORT COMPANY
Statement Re Computation of Per Share Earnings
(In thousands, except per share data)


                                                 Three Months Ended
                                                      March 31,
                                                -------------------- 
                                                        1999  
                                                --------------------
Net income                                       $1,305      $1,175 
                                                ====================
Shares:
Beginning shares outstanding                      2,422       2,400 
Shares issued under executive incentive plan        --          -- 
                                                --------------------
      Basic shares outstanding                    2,422       2,400
Dilutive effect of outstanding options              --          -- 
                                               ---------------------
      Diluted shares outstanding                  2,422       2,400 
                                               =====================

Basic and diluted earnings per share             $  .54      $  .49
                                               =====================
Exhibit 10.7


 


TERMINATION


 


Reference is made to the letter agreement,
dated as of December 12, 2014 (the “Agreement”), between CB Pharma Acquisition Corp. (the “Company”)
and Fortress Biotech, Inc. (formerly Coronado Biosciences, Inc.) (the “Admin Provider”).


 


The parties hereby agree that the Agreement
is terminated effective as of the date hereof and that the Company does not owe any further amounts to the Admin Provider pursuant
to the Agreement and that any amounts accrued as of the date hereof pursuant to the Agreement shall be forgiven.


 


IN WITNESS WHEREOF, the undersigned have
caused this termination to be executed as of May 20, 2016.


 


	 	CB PHARMA ACQUISITION CORP.
	 	 	 
	 	By:	/s/ Lindsay A. Rosenwald
	 	Name: Lindsay A. Rosenwald
	 	Title: CEO
	 	 
	 	FORTRESS BIOTECH, INC.
	 	 	 
	 	By:	/s/ Lindsay A. Rosenwald
	 	Name: Lindsay A. Rosenwald
	 	Title: CEO
Francois GIVENS, petitioner, v. CALIFORNIA.

No. 16-6652.

Supreme Court of the United States

Jan. 9, 2017.

Petition for writ of certiorari to the Court of Appeal of California, Third Appellate District denied.
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Adolor Corporation:

We consent to
the incorporation by reference in the registration statements on Form S-8 (No. 333-51222, No. 333-62428, No. 333-100585, No. 333-105912, No. 333-134647 and No. 333-151628) and registration statement on Form S-3 (No.
333-167105) of Adolor Corporation of our report dated February 24, 2011, with respect to the consolidated balance sheets of Adolor Corporation and subsidiary as of December 31, 2010 and 2009, and the related consolidated statements of
operations, comprehensive loss, stockholders equity, and cash flows for each of the years in the three-year period ended December 31, 2010, and the related consolidated financial statement schedule, which report appears in the
December 31, 2010 annual report on Form 10-K of Adolor Corporation.



|                                            
|--------------------------------------------
|/s/ KPMG LLP                                
|                                            
|Philadelphia, Pennsylvania
February 24, 2011
<TABLE> <S> <C>

<ARTICLE>  5
<LEGEND>
     The financial data schedule contains summary financial information
     extracted from the form 10-K of Howell Corporation for the year
     ended December 31, 1999, and is qualified in its entirety by reference
     to such financial statements.
</LEGEND>
<MULTIPLIER>             1000

<S>                        <C>
<PERIOD-TYPE>              12-mos
<FISCAL-YEAR-END>          Dec-31-1999
<PERIOD-END>               Dec-31-1999
<CASH>                           2112
<SECURITIES>                        0
<RECEIVABLES>                   10978
<ALLOWANCES>                      161
<INVENTORY>                        40
<CURRENT-ASSETS>                17557
<PP&E>                         406295
<DEPRECIATION>                 313249
<TOTAL-ASSETS>                 117983
<CURRENT-LIABILITIES>           14587
<BONDS>                         82000
<PREFERRED-MANDATORY>               0
<PREFERRED>                       690
<COMMON>                         5472
<OTHER-SE>                      14518
<TOTAL-LIABILITY-AND-EQUITY>   117983
<SALES>                         48310
<TOTAL-REVENUES>                48310
<CGS>                           29764
<TOTAL-COSTS>                   29764
<OTHER-EXPENSES>                    0
<LOSS-PROVISION>                    0
<INTEREST-EXPENSE>               7329
<INCOME-PRETAX>                  7586
<INCOME-TAX>                     2641
<INCOME-CONTINUING>              4945
<DISCONTINUED>                  (7845)
<EXTRAORDINARY>                     0
<CHANGES>                           0
<NET-INCOME>                    (2900)
<EPS-BASIC>                   (0.97)
<EPS-DILUTED>                   (0.96)


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company.  The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).

The notices are available for immediate inspection at the Federal Reserve Bank indicated.  The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors.  Comments must be received not later than July 9, 2001

**A.  Federal Reserve Bank of San Francisco**                     (Maria Villanueva, Consumer Regulation Group) 101 Market Street, San Francisco, California  94105-1579:                

*1.  Terrance Ray Sullivan*, Elko, Nevada; Carol Ann Sullivan, Elko, Nevada; Patrick Sean Sullivan, Elko, Nevada; Terrance LeRoy Sullivan, Twin Falls, Idaho; Deborah Ann Hall, Twin Falls, Idaho; Darren Eugene Hall, Twin Falls, Idaho; Terrance Ryan Sullivan, Las Vegas, Nevada; Gary Phillip Sullivan, Staten Island, New York; Ralph William Farley, Laguna Woods, California; and Iris Gertrude Farley, Laguna Woods, California; all to acquire additional voting shares of Great Basin Financial Corporation, Elko, Nevada, and thereby indirectly acquire additional voting of Great Basin Bank of Nevada, Elko, Nevada.                

Board of Governors of the Federal Reserve System, June 19, 2001.

Robert deV. Frierson

Associate Secretary of the Board.

[FR Doc. 01-15732 Filed 6-21-01; 8:45 am]

BILLING CODE 6210-01-S
II-OlOl3

From:

Sent:

To:

Subject:

wilfredo maldonado <wmaldonado@legal-aid.org>

Thursday, December 2, 2010 9:09 AM

dfadefinitions <dfadefinitions@CFTC.gov>

Re: No loopholes in Dodd-Frank

1) Securities and Exchange Commission/Commodities Futures Trading Commission, Re: Commercial Risk (CFTC PIN

3235-AK65, SEC File Number $7-12-10)

Dear Commissioners Shapiro and Gensler: Don’t let the American Bankers Association (ABA) redefine important terms like

"commercial risk" to keep banks that engage in risky derivatives trading from complying with transparency and business

conduct requirements. Commercial risk should not be expanded to include financial risk. Accepting the ABA argument

would open the door for exemptions for risky hedge funds and insurance companies.

2) Commodities Futures Trading Commission, Re: Position Limits (PIN 3038-AD 17 )

Dear Commissioner Gensler: The CFTC needs to set strong position limits to crack down on the energy and food commodity

speculation that serves no productive purpose. I urge the Commission to define limits that will address not only manipulation,

but also excessive speculation, which will require a stricter approach.

3) U.S. Department of the Treasury, Re: FX Swaps (75 FR 66426 Document Number 2010-27274)

Dear Secretary Geithner: Just say "no" to foreign exchange traders who want to exempt foreign currency derivatives from the

clearing and transparency requirements of the

Dodd-Frank Act. $4 trillion dollars a day is traded in these highly-leveraged swaps and this number may increase to over $10

trillion in a decade. As the head of the Financial

Stability Oversight Board your job is to decrease risk in the system, not encourage off-book trading and opaque markets.

wilfredo maldonado

skillman st

brooklyn, NY 11205
II-01172

From:

Sent:

To:

Subject:

Elaina Feliciano <etfeliciano@sbcglobal.net>

Wednesday, December 1, 2010 7:58 PM

dfadefinitions <dfadefinitions@CFTC.gov>

Re: No loopholes in Dodd-Frank

1) Securities and Exchange Commission/Commodities Futures Trading Commission, Re: Commercial Risk (CFTC PIN

3235-AK65, SEC File Number $7-12-10)

Dear Commissioners Shapiro and Gensler: Don’t let the American Bankers Association (ABA) redefine important terms like

"commercial risk" to keep banks that engage in risky derivatives trading from complying with transparency and business

conduct requirements. Commercial risk should not be expanded to include financial risk. Accepting the ABA argument

would open the door for exemptions for risky hedge funds and insurance companies.

2) Commodities Futures Trading Commission, Re: Position Limits (PIN 3038-AD 17 )

Dear Commissioner Gensler: The CFTC needs to set strong position limits to crack down on the energy and food commodity

speculation that serves no productive purpose. I urge the Commission to define limits that will address not only manipulation,

but also excessive speculation, which will require a stricter approach.

3) U.S. Department of the Treasury, Re: FX Swaps (75 FR 66426 Document Number 2010-27274)

Dear Secretary Geithner: Just say "no" to foreign exchange traders who want to exempt foreign currency derivatives from the

clearing and transparency requirements of the

Dodd-Frank Act. $4 trillion dollars a day is traded in these highly-leveraged swaps and this number may increase to over $10

trillion in a decade. As the head of the Financial

Stability Oversight Board your job is to decrease risk in the system, not encourage off-book trading and opaque markets.

Elaina Feliciano

2927 Ivanhoe Glen

Fitchburg, WI 53711
EXHIBIT 32.2

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Annual Report of ACL Semiconductors Inc. (the
"Company") on Form 10-K for the year ended December 31, 2004 filed with the
Securities and Exchange Commission (the "Report"), I, Kenneth Lap-Chan, Chief
Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S. C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

         (1)      The Report fully complies with the requirements of Section
                  13(a) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the consolidated financial condition of
                  the Company as of the dates presented and the consolidated
                  result of operations of the Company for the periods presented.



Date:    April 14, 2005          /s/ KENNETH LAP-YIN CHIN
                                --------------------------------------
                                       Kenneth Lap-Yin Chan
                                       Chief Financial Officer of
                                       ACL Semiconductors Inc.


This certification has been furnished solely pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed original of this written statement required by Section 906 has been
provided to ACL Semiconductors, Inc. and will be retained by ACL Semiconductors
Inc. and furnished to the Securities and Exchange Commission or its staff upon
request.